Showing results (31-40 of 2,229) with videos related to
Sort By:
Pageof 223
Cancer Biotherapy & Radiopharmaceuticals|September 28, 2019
Role of Diffusional Kurtosis Imaging in Evaluating the Efficacy of Transcatheter Arterial Chemoembolization in Patients with Liver CancerXin Luo, Yuhua Li, Qun Shang, et al.Cancer Biotherapy & Radiopharmaceuticals|March 31, 2017
In Vitro Incorporation of Radioiodinated Eugenol on Adenocarcinoma Cell Lines (Caco2, MCF7, and PC3)Emine Dervis, Ayfer Yurt Kilcar, Emin Ilker Medine, et al.Cancer Biotherapy & Radiopharmaceuticals|March 12, 2019
Inhibition of Autophagy Improves the Efficacy of Abiraterone for the Treatment of Prostate CancerXiaokun Ma, Liyuan Zou, Xing Li, et al.Cancer Biotherapy & Radiopharmaceuticals|March 14, 2019
89Zr-DFO-Cetuximab as a Molecular Imaging Agent to Identify Cetuximab Resistance in Head and Neck Squamous Cell CarcinomaRaquel Benedetto, Adriana V F Massicano, Bryant K Crenshaw, et al.Cancer Biotherapy & Radiopharmaceuticals|September 21, 2019
Curcumin Promoted miR-34a Expression and Suppressed Proliferation of Gastric Cancer CellsChunlin Sun, Shuping Zhang, Changhai Liu, et al.Cancer Biotherapy & Radiopharmaceuticals|August 20, 2019
In Vitro Performance of Published Glypican 3-Targeting Peptides TJ12P1 and L5 Indicates Lack of Specificity and PotencyRose M Berman, Olivia J Kelada, Nicholas T Gutsche, et al.Cancer Biotherapy & Radiopharmaceuticals|July 18, 2019
Downregulated Long Noncoding RNA GAS5 Fails to Function as Decoy of CEBPB, Resulting in Increased GDF15 Expression and Rapid Ovarian Cancer Cell ProliferationLin-Lin Guo, Shan-Feng WangCancer Biotherapy & Radiopharmaceuticals|January 22, 2021
Preclinical Chimeric Antibody Chimeric Antigen Receptor T Cell Progress in Digestive System CancersPeng Lü, Songlin Qiu, Ye Pan, et al.Cancer Biotherapy & Radiopharmaceuticals|January 22, 2021
LncRNA SNHG6 Promotes Wilms' Tumor Progression Through Regulating miR-429/FRS2 AxisYingjie Wang, Junli Liu, Qiying Yao, et al.Cancer Biotherapy & Radiopharmaceuticals|February 19, 2021
Acts as a Promising Novel Biomarker for the Prognosis of Patients with Hepatocellular CarcinomaXianfeng Zhang, Xianjun Zhang, Xinguo Li, et al.Pageof 223